Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 December 2023

The Committee adopted by consensus a positive opinion for a variation requiring assessment for Solensia (frunevetmab) to implement the outcome of the MAH’s signal management…

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/news/meeting-highlights-committee-veterinary-medicinal-products-cvmp-5-7-december-2023https://www.ema.europa.eu/en/news/meeting-highlights-committee-veterinary-medicinal-products-cvmp-5-7-december-2023
Retrieved on: 
Monday, December 18, 2023
Information
Tags: 
Ixodes, European Commission, Decision-making, GMP, SPC, Sheep, The Committee, UPD, MRP, QRD, EMA, Civil service commission, Q&A, DCP, Committee, Product, Science, MAH, Breeding, QR, CVMP, Review, Female, Guideline, CP, Dog, Cattle, Classification, Risk management, Automotive industry, Vaccine, Medical device, Real estate, Regulation, Frunevetmab
Geotags: 
EU
Summary
Key Points: 


The Committee adopted by consensus a positive opinion for a variation requiring assessment for Solensia (frunevetmab) to implement the outcome of the MAH’s signal management…

Copyright: 
2023 European Medicines Agency. All Rights Reserved.